ASCO GUIDELINES Bundle

Medication-Related Osteonecrosis of the Jaw

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475476

Contents of this Issue

Navigation

Page 9 of 13

10 Treatment Table 5. Treatment Strategies by Stage of MRONJ a Staging of MRONJ b Treatment Strategies c Stage 2: Exposed and necrotic bone or fistulas that probes to bone associated with infection as evidenced by pain and erythema in the region of exposed bone with or without purulent drainage • Symptomatic treatment with oral antibiotics and topical antibacterial rinse • Pain control • Debridement to relieve soft tissue irritation and infection control • Clinical follow-up on a q8week basis by dental specialist with communication of lesion status to oncologist • Patient education and reduction of modifiable risk factors Stage 3: Exposed and necrotic bone or a fistula that probes to bone in patients with pain, infection, and ≥1 of the following : exposed and necrotic bone extending beyond the region of alveolar bone (i.e., inferior border and ramus in mandible maxillary sinus, and zygoma in maxilla) resulting in pathologic fracture, extraoral fistula, oral antral or oral nasal communication, or osteolysis extending to inferior border of the mandible or sinus floor • Symptomatic treatment with oral antibiotics and topical antibacterial rinse • Pain control • Surgical debridement or resection for long-term palliation of infection and pain • Clinical follow-up on a q8week basis by dental specialist with communication of lesion status to oncologist • Patient education and reduction of modifiable risk factors a Adapted from Ruggiero et al. 2014. b Exposed or probable bone in the maxillofacial region without resolution for longer than 8 weeks in patients treated with an anti-resorptive or an angiogenic inhibitor and who have not received radiation therapy to the jaws. c Regardless of disease stage, mobile segments of bony sequestrum should be removed without exposing uninvolved bone. Extraction of symptomatic teeth within exposed necrotic bone should be considered because it is unlikely that extraction will exacerbate the established necrotic process. (cont'd)

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Medication-Related Osteonecrosis of the Jaw